Taro Pharmaceutical Industries Ltd reports results for the quarter ended in September - Earnings Summary

Taro Pharmaceutical Industries

29/10/2021 24:55

* Taro Pharmaceutical Industries Ltd  TARO.N  reported quarterly
adjusted earnings of 66 cents​​ per share for the quarter ended
in September. The lone analyst forecast for the quarter was
for earnings of $1.02 per share.
* Revenue fell 7.6% to $131.99 million from a year ago; 
analysts expected $153.23 million. 
* Taro Pharmaceutical Industries Ltd's reported EPS for the
quarter was 62 cents​.
* The mean earnings estimate of analysts was unchanged in the
last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Taro Pharmaceutical Industries Ltd shares had fallen by 5.8%
this quarter and lost 18.3% so far this year.
* The company reported quarterly net income of $23.32 million.
* Wall Street's median 12-month price target for Taro
Pharmaceutical Industries Ltd is $82.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated October 28 at 11:55 p.m.
 ​All figures in US dollars unless otherwise stated